These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18677381)

  • 1. [Correlation of telomere length and the expression of its regulating proteins in mesenchymal sarcomas].
    Chi YK; Shen Q; Wang JC; Zheng XZ; Hou L; Zhang B
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):363-8. PubMed ID: 18677381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
    Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A
    J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.
    Butler KS; Hines WC; Heaphy CM; Griffith JK
    Cancer Med; 2012 Oct; 1(2):165-75. PubMed ID: 23342266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrokine 1 induces senescence and apoptosis through regulating telomere length in gastric cancer.
    Yoon JH; Seo HS; Choi WS; Kim O; Nam SW; Lee JY; Park WS
    Oncotarget; 2014 Nov; 5(22):11695-708. PubMed ID: 25344918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, MIB1, and Topoisomerase IIalpha protein expression.
    Miracco C; De Santi MM; Luzi P; Lalinga AV; Laurini L; De Nisi MC; Angeloni G; Brogi M; Cardone C; Carducci A; Arcuri F; Tosi P; Rubino G; Pirtoli L
    Int J Oncol; 2003 Dec; 23(6):1529-35. PubMed ID: 14612923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere-associated factor expression in replicative senescence of human embryonic lung fibroblasts.
    Du H; Yang L; Xu XY; Hai L; Han YQ; Shi YX
    Genet Mol Res; 2015 Aug; 14(3):9269-76. PubMed ID: 26345860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.
    Kato M; Nakayama M; Agata M; Yoshida K
    Tumour Biol; 2013 Apr; 34(2):723-33. PubMed ID: 23247865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation.
    Klapper W; Krams M; Qian W; Janssen D; Parwaresch R
    Br J Cancer; 2003 Aug; 89(4):713-9. PubMed ID: 12915884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.
    Gao J; Zhang J; Long Y; Lu X
    Asia Pac J Clin Oncol; 2011 Dec; 7(4):339-45. PubMed ID: 22151982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes.
    Escoffier E; Rezza A; Roborel de Climens A; Belleville A; Gazzolo L; Gilson E; Duc Dodon M
    Retrovirology; 2005 Dec; 2():77. PubMed ID: 16354306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POT1 as a terminal transducer of TRF1 telomere length control.
    Loayza D; De Lange T
    Nature; 2003 Jun; 423(6943):1013-8. PubMed ID: 12768206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
    Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
    Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomeric 3' overhangs in chronic HBV-related hepatitis and hepatocellular carcinoma.
    Lee JE; Oh BK; Choi J; Park YN
    Int J Cancer; 2008 Jul; 123(2):264-272. PubMed ID: 18449889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alterations of MDM2 and p53 genes in bone tumors].
    Zhou X; Gao L; Zhe X
    Zhonghua Bing Li Xue Za Zhi; 1997 Oct; 26(5):270-2. PubMed ID: 10374333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRF1 as a major contributor for telomeres' shortening in the context of obesity.
    Grun LK; Teixeira NDR; Mengden LV; de Bastiani MA; Parisi MM; Bortolin R; Lavandoski P; Pierdoná V; Alves LB; Moreira JCF; Mottin CC; Jones MH; Klamt F; Padoin AV; Guma FCR; Barbé-Tuana FM
    Free Radic Biol Med; 2018 Dec; 129():286-295. PubMed ID: 30268887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. POT1 deficiency alters telomere length and telomere-associated gene expression in human gastric cancer cells.
    Ning X; Yang S; Wang R; Zhang R; Guo L; Tie J; Cheng Y; Wang G; Wan S; Fang D
    Eur J Cancer Prev; 2010 Sep; 19(5):345-51. PubMed ID: 20517159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer.
    Poonepalli A; Banerjee B; Ramnarayanan K; Palanisamy N; Putti TC; Hande MP
    Genes Chromosomes Cancer; 2008 Dec; 47(12):1098-109. PubMed ID: 18720522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
    Terasaki T; Kyo S; Takakura M; Maida Y; Tsuchiya H; Tomita K; Inoue M
    Oncol Rep; 2004 Jun; 11(6):1307-11. PubMed ID: 15138570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas.
    Scheel C; Schaefer KL; Jauch A; Keller M; Wai D; Brinkschmidt C; van Valen F; Boecker W; Dockhorn-Dworniczak B; Poremba C
    Oncogene; 2001 Jun; 20(29):3835-44. PubMed ID: 11439347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
    Kelleher C; Kurth I; Lingner J
    Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.